Cambridge Investment Research Advisors, Inc. Ark Genomic Revolution ETF (De Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 94,117 shares of ARKG stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
94,117
Previous 93,278
0.9%
Holding current value
$2.39 Million
Previous $2.2 Million
11.02%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding ARKG
# of Institutions
278Shares Held
21MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$87.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$83.5 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$65 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$60 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$30.6 Million0.0% of portfolio